EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ultrasonic Microbubble Cavitation Deliver Gal-3 shRNA to Inhibit Myocardial Fibrosis after Myocardial Infarction

Wenqu Li, Qiaofeng Jin, Li Zhang iD, Shukun He, Yishu Song, Lingling Xu, Cheng Deng, Lufang Wang, Xiaojuan Qin, Mingxing Xie iD

Pharmaceutics · 22.02.2023 · 15 (3) · 729

DOI: 10.3390/pharmaceutics15030729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 22.02.2023. Verfasst von Wenqu Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave., Wuhan 43…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key R&D plan of Hubei Province, Shenzhen Science and Technology under Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Galectin-3 (Gal-3) participates in myocardial fibrosis (MF) in a variety of ways. Inhibiting the expression of Gal-3 can effectively interfere with MF. This study aimed to explore the value of Gal-3 short hairpin RNA (shRNA) transfection mediated by ultrasound-targeted microbubble destruction (UTMD) in anti-myocardial fibrosis and its mechanism. A rat model of myocardial infarction (MI) was established and randomly divided into control and Gal-3 shRNA/cationic microbubbles + ultrasound (Gal-3 shRNA/CMBs + US) groups. Echocardiography measured the left ventricular ejection fraction (LVEF) weekly, and the heart was harvested to analyze fibrosis, Gal-3, and collagen expression. LVEF in the Gal-3 shRNA/CMB + US group was improved compared with the control group. On day 21, the myocardial Gal-3 expression decreased in the Gal-3 shRNA/CMBs + US group. Furthermore, the proportion of the myocardial fibrosis area in the Gal-3 shRNA/CMBs + US group was 6.9 ± 0.41% lower than in the control group. After inhibition of Gal-3, there was a downregulation in collagen production (collagen I and III), and the ratio of Col I/Col III decreased. In conclusion, UTMD-mediated Gal-3 shRNA transfection can effectively silence the expression of Gal-3 in myocardial tissue, reduce myocardial fibrosis, and protect the cardiac ejection function.

Schlagwörter

Stichwörter der Autor:innen

Galectin-3microbubblesmyocardial fibrosisultrasonography

Autor:innen und Institutionen

  • Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave., Wuhan 430022, China.
  • Hubei Province Clinical Research Center for Medical Imaging, Wuhan 430022, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.

ORCID-Profile: Li Zhang, Mingxing Xie

Förderung

  • National Natural Science Foundation of China
  • Key R&D plan of Hubei Province
  • Shenzhen Science and Technology under Grant
  • Natural Science Foundation of China
  • Key R&D plan of Hubei Province
  • Shenzhen Science and Technology

Zitieren

APA

Li, W., Jin, Q., Zhang, L., He, S., Song, Y., Xu, L., Deng, C., Wang, L., Qin, X., & Xie, M. (2023). Ultrasonic Microbubble Cavitation Deliver Gal-3 shRNA to Inhibit Myocardial Fibrosis after Myocardial Infarction. Pharmaceutics, 15(3), 729. https://doi.org/10.3390/pharmaceutics15030729

Vancouver

Li W, Jin Q, Zhang L, He S, Song Y, Xu L, et al. Ultrasonic Microbubble Cavitation Deliver Gal-3 shRNA to Inhibit Myocardial Fibrosis after Myocardial Infarction. Pharmaceutics. 2023;15(3):729. doi:10.3390/pharmaceutics15030729

BibTeX
@article{Li2023,
  author = {Li, Wenqu and Jin, Qiaofeng and Zhang, Li and He, Shukun and Song, Yishu and Xu, Lingling and Deng, Cheng and Wang, Lufang and Qin, Xiaojuan and Xie, Mingxing},
  title = {Ultrasonic Microbubble Cavitation Deliver Gal-3 shRNA to Inhibit Myocardial Fibrosis after Myocardial Infarction},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {729},
  doi = {10.3390/pharmaceutics15030729}
}
Kostenlos starten →